First Miris HMA™ sold to Republic of Belarus

Report this content

The knowledge of the importance of human milk for preterm babies is growing and with this increasing knowledge efforts are being made to increase the number of milk banks globally. For many countries this means opening of their first milk bank. By the end of 2021 Republic of Belarus is joining the milk banking community when it is opening its first Milk Bank. As many others, they have chosen Miris HMA™ to further secure the quality of the milk they will deliver to hospitals.

At the end of 2021 the Republic of Belarus first donor human milk bank is planned to open. The milk bank will provide lifesaving human milk to preterm babies admitted to the NICUs they serve. This will be the first milk bank in Republic of Belarus and will set the stage for future milk banks in the country. Miris is happy to inform that the Miris HMA™ has been chosen as one of the standard equipment’s of the milk bank. Miris HMA™ will be used to provide information on the nutritional content of the milk delivered to NICUs and aid the clinicians in the nutritional management of preterm babies.

“We are so happy to see the increasing number of milk banks. Especially for countries opening their first milk bank this will make a great difference for the care of their tiniest patients” says Camilla Sandberg, CEO Miris.

Miris has chosen Bioline-BS LLC Belarus as distributor for Republic of Belarus. Biolone-BS LLC is part of BIOLINE GROUP, with headquarters in St. Petersburg, and representatives in 9 different cities covering the whole territory of the Russian Federation.

“This is the first state-wide project for our country for human milk banking. Opening a breast milk bank will allow premature newborns and toddlers of mothers who do not have the opportunity to breastfeed to receive adequate nutrition from the first days of life and develop harmoniously. Bioline-BS (Belarus), part of the Bioline group of companies, is equipping the breast milk bank. Bioline-BS is pleased to cooperate with Miris and expresses respect and gratitude for the consulting assistance, timely delivery, efficiency in work and professionalism. We look forward to further successful cooperation” says Olga Solovey, Foreign trade specialist at Bioline-BS LLC, Belarus.

“This is our first project with Bioline and our first HMA sold to Republic of Belarus. We are honored to be part of the pilot project for human milk banking in Republic of Belarus. As the knowledge of the benefits of human milk for preterm babies grow, we firmly believe more milk banks will open” Camilla says. “Bioline has worked closely with the neonatologists heading this project and we look forward to our company’s future cooperation.”

For more information:
Camilla Myhre Sandberg, VD Miris Holding AB. Mobil: +46 18 14 69 07, E-post:

About Miris
Miris is a global MedTech company who develops and sells instruments and solutions for human milk analysis. The products are used at neonatal intensive care units, milk banks and research centers worldwide. The purpose is to enable clinicians to practice individualized nutrition of human milk using target fortification, thus giving preterm babies the best possible start in life. Miris received FDA clearance for the Human Milk Analyzer™ for the US market in December 2018. The mission is to make individualized nutrition, based on breast milk, available globally to improve neonatal health. Miris Holding AB is listed on the Spotlight Stock Market in Sweden.